The European Medicines Agency (EMA) published its 11th report on the European Surveillance of Veterinary Antimicrobial Consumption on November 23, 2021 (ESVAC). The report provides information on veterinary antimicrobial agent sales in European countries in 2019 and 2020. It also includes a chapter describing changes in veterinary antimicrobial consumption from 2010 to 2020.
According to the ESVAC annual report, European countries have significantly reduced the use of antimicrobials in animals. Overall sales of veterinary antimicrobials in European countries were 43,2 percent lower in 2020 than in 2011, according to data from the 25 countries that provided input for the entire 2011-2020 period. Another encouraging trend is the decline in the use of Critically Important AntibioticsAnother very good news is the decreasing trend seen for the Critically Important Antibiotics. In particular, third- and fourth-generation cephalosporin sales fell by 33%, polymyxins fell by 76%, fluoroquinolones fell by 13%, and other quinolones fell by 85%.
The Agency launched the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project in September 2009, in response to a request from the European Commission to develop a harmonized approach to the collection and reporting of data on the use of antimicrobial agents in animals from Member States.
Leave a reply